2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the French Temporary Authorization for Use (ATU)
De La Motte Rouge, T, Pautier, P, Alexandre, J, Ray-Coquard, I, Cottu, P, Rodrigues, M, Follana, P, Floquet, A, Lortholary, A, Heudel, P.E, Combe, P, Joly, F, Suau, D, Maribas, D, Licour, M, Porte, I. De La, Varoqueaux, N, Pujade-Lauraine, E
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Osimertinib in EGFR T790M positive advanced NSCLC (aNSCLC) – real–life data from the French temporary authorization for use (ATU) program
Planchard, D., Pérol, M., Quantin, X., Cortot, A., Cadranel, J., Schott, R., Dansin, E., Fraboulet, G., Moro-Sibilot, D., Soria, J.-C., Mazieres, J., Moulec, S.L.e., Coudurier, M., Pichon, E., Licour, M., Maribas, D., Gourion, A., Radu, N., Varoqueaux, N., Chouaid, C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article